Medium materiality6/10
Goldman Sachs Starts United Therapeutics Corp. (UTHR) at Sell
Why it may matterVerify against the original reporting
Sell
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Goldman Sachs initiates coverage on United Therapeutics (UTHR) with a Sell rating and a $321 price target; current price $489.42.
- Goldman Sachs initiates UTHR with Sell and $321 target; price $489.42.
- Sell rating with a $321 target vs $489.42 price.
Key facts
- 01
Target: $321
- 02
Posted price: $489.42
- 03
Analyst firm: Goldman Sachs
- 04
Analyst: Andrea Newkirk
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.